This Week in PNAS

Metabolomics could be a key tool for personalized medicine, say researchers from Metabolon in the Proceedings of the National Academy of Sciences. They conducted a metabolomics analysis of plasma samples from a cohort of 80 healthy volunteers, profiling some 600 metabolites and covering 72 biochemical pathways.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.